Cerence Announces Third Quarter Fiscal Year 2023 Results

In this article:
Cerence Operating CompanyCerence Operating Company
Cerence Operating Company

Headlines

  • On track to achieve full fiscal year revenue guidance

  • Strategic wins for connected services for a major Japanese OEM and Emergency Vehicle Detection for a major Korean OEM’s ADAS platform

  • Two-wheeler design win for major Japanese brand; four two-wheeler manufacturers start production (SOP)

  • Successful convertible note offering leading to approximately $8 million in annual interest expense savings

BURLINGTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its third quarter fiscal year 2023 results for the quarter ended June 30, 2023.

Results Summary (1)

(in millions, except per share data)

 

Three Months Ended

 

Nine Months Ended

 

June 30,

 

June 30,

 

2023

 

2022

 

2023

 

2022

GAAP Revenue

$61.7

 

$89.0

 

$213.7

 

$269.7

GAAP Gross Margin

66.0%

 

72.8%

 

66.2%

 

73.0%

Non-GAAP Gross Margin

66.5%

 

73.7%

 

67.7%

 

75.3%

GAAP Operating Margin

-13.8%

 

17.7%

 

-14.6%

 

16.7%

Non-GAAP Operating Margin

0.5%

 

29.4%

 

8.1%

 

30.6%

GAAP Net Loss

($16.5)

 

($99.3)

 

($44.7)

 

($80.7)

GAAP Net Loss Margin

-26.7%

 

-111.5%

 

-20.9%

 

-29.9%

Non-GAAP Net (Loss) Income

($1.7)

 

$17.0

 

$10.8

 

$55.9

Adjusted EBITDA

$2.8

 

$28.5

 

$24.9

 

$89.4

Adjusted EBITDA Margin

4.5%

 

32.0%

 

11.7%

 

33.2%

GAAP Net Loss per Share - diluted

($0.41)

 

($2.53)

 

($1.11)

 

($2.06)

Non-GAAP Net (Loss) Income per Share - diluted

($0.04)

 

$0.43

 

$0.27

 

$1.34


(1)

Please refer to the “Discussion of Non-GAAP Financial Measures” and “Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures” included elsewhere in this release for more information regarding our use of non-GAAP financial measures.

 

 

Stefan Ortmanns, Chief Executive Officer at Cerence, commented, “Our focus on operational excellence and delivering on our commitments continued to drive strong results in Q3, with revenue for the quarter, as well as most of the key profitability metrics, at or above the high end of our guidance range.”

“The core automotive business remained strong with the launch of three new global OEM platforms in the quarter and continued growth in emerging markets. And, we continue to make steady progress in the two-wheeler market, with four starts-of-production in the quarter and a key strategic win with a major Japanese brand.”

“As we look to the future of the in-car experience, we are deeply focused on leveraging generative AI and large language models at meaningful points in the Cerence product architecture. Iqbal Arshad, Chief Technology Officer, and Nils Schanz, Chief Product Officer, are keenly focused on a product strategy that positions Cerence as the primary enabler for the coexistence of large language models and consumer tech assistants in the car, operating under a uniquely branded OEM experience that prioritizes creating true value for end users.”

Cerence Key Performance Indicators

To help investors gain further insight into the Cerence business and its performance, management provides a set of key performance indicators that includes:

Key Performance Indicator1

Q3FY23

Percent of worldwide auto production with Cerence Technology (TTM)

54%

Average contract duration - years (TTM):

6.4

Repeatable software contribution (TTM):

72%

Change in number of Cerence connected cars shipped2 (TTM over prior year TTM)

32%

Change in billings per car3 (TTM over prior year TTM) (excludes Legacy contract4)

-6%


(1)

Please refer to the “Key Performance Indicators” included elsewhere in this release for more information regarding the definition and our use of key performance indicators.

(2)

Based on IHS Markit data, global auto production increased 13% over the same time period ended on June 30, 2023.

(3)

The billings per car KPI has been modified to exclude professional services in the calculation.

(4)

Legacy contract is a connected services contract with Toyota acquired by Nuance through a 2013 acquisition.

 

 

Fourth Quarter Fiscal Year 2023 Outlook

For the fiscal quarter ending September 30, 2023, revenue is expected to be in the range of $72 million to $76 million. The guidance includes approximately $13 million of fixed contracts, bringing the total for the fiscal year to approximately $37 million.

GAAP Net Loss is expected to be in the range of ($13) million to ($9) million. Adjusted EBITDA is expected to be in the range of approximately $10 million to $14 million.

For the full fiscal year ending September 30, 2023, the company has raised the low end of the initial guidance with revenue now expected to be in the range of $286 million to $290 million. GAAP Net Loss is expected to be in the range of ($58) million to ($54) million. Adjusted EBITDA is expected to be in the range of approximately $34 million to $38 million.

The adjusted EBITDA guidance excludes acquisition-related costs, amortization of acquired intangible assets, stock-based compensation, and restructuring and other costs.

Additional details regarding guidance will be provided during the earnings call.

Third Quarter Conference Call

The company will host a live conference call and webcast with slides to discuss the results today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time. Interested investors and analysts are invited to dial into the conference call by using the following link: Register Here

Webcast access will also be available on the Investor Information section of the company’s website at https://www.cerence.com/investors/events-and-resources.

A replay of the webcast can be accessed by visiting the company’s website 90 minutes following the conference call at https://www.cerence.com/investors/events-and-resources.

Forward Looking Statements

Statements in this press release regarding: Cerence’s future performance, results and financial condition; expected growth; opportunities; business, industry and market trends; strategy regarding fixed contracts and its impact on financial results; backlog; demand for Cerence products; innovation and new product offerings; and management’s future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “anticipates,” “expects,” “intends” or “estimates” or similar expressions) should also be considered to be forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risk, uncertainties and other factors, which may cause actual results or performance of the company to be materially different from any future results or performance expressed or implied by such forward-looking statements, including, but not limited to: the highly competitive and rapidly changing market in which we operate; adverse conditions in the automotive industry, the related supply chain and semiconductor shortage, or the global economy more generally; the impacts of the COVID-19 pandemic on our and our customers’ businesses; the impact of the war in Ukraine on our and our customers’ businesses; our ability to control and successfully manage our expenses and cash position; escalating pricing pressures from our customers; the impact on our business of the transition to a lower level of fixed contracts, including the failure to achieve such a transition; our failure to win, renew or implement service contracts; the cancellation or postponement of existing contracts; the loss of business from any of our largest customers; effects of customer defaults; our inability to successfully introduce new products, applications and services; our strategy to increase cloud offerings; the inability to recruit and retain qualified personnel; disruptions arising from transitions in management personnel; cybersecurity and data privacy incidents; failure to protect our intellectual property; defects or interruptions in service with respect to our products; fluctuating currency rates and interest rates; inflation; financial and credit market volatility; and the other factors discussed in our most recent Annual Report on Form 10-K for the fiscal year ended September 30, 2022, quarterly reports on Form 10-Q, and other filings with the Securities and Exchange Commission. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date made. We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by law.

Discussion of Non-GAAP Financial Measures

We believe that providing the non-GAAP information in addition to the GAAP presentation, allows investors to view the financial results in the way management views the operating results. We further believe that providing this information allows investors to not only better understand our financial performance, but more importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such performance. The non-GAAP information should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP.

We utilize a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of the business, for making operating decisions and for forecasting and planning for future periods. While our management uses these non-GAAP financial measures as a tool to enhance their understanding of certain aspects of our financial performance, our management does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial statements.

Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial statements, allows for greater transparency in the review of our financial and operational performance. In assessing the overall health of the business during the three and nine months ended June 30, 2023 and 2022, our management has either included or excluded the following items in general categories, each of which is described below.

Adjusted EBITDA

Adjusted EBITDA is defined as net income attributable to Cerence Inc. before net income (loss) attributable to income tax (benefit) expense, other income (expense) items, net, depreciation and amortization expense, and excluding acquisition-related costs, amortization of acquired intangible assets, stock-based compensation, and restructuring and other costs, net or impairment charges related to fixed and intangible assets and gains or losses on the sale of long-lived assets, if any. From time to time we may exclude from Adjusted EBITDA the impact of events, gains, losses or other charges (such as significant legal settlements) that affect the period-to-period comparability of our operating performance. Other income (expense) items, net include interest expense, interest income, and other income (expense), net (as stated in our Condensed Consolidated Statement of Operations). Our management and Board of Directors use this financial measure to evaluate our operating performance. It is also a significant performance measure in our annual incentive compensation programs.

Restructuring and other costs, net.

Restructuring and other charges, net include restructuring expenses as well as other charges that are unusual in nature, are the result of unplanned events, and arise outside the ordinary course of our business such as employee severance costs, costs for consolidating duplicate facilities, third-party fees relating to the modification of our convertible debt, release of a pre-acquisition contingency, and separation costs directly attributable to the Cerence business becoming a standalone public company.

Amortization of acquired intangible assets.

We exclude the amortization of acquired intangible assets from non-GAAP expense and income measures. These amounts are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions. Providing a supplemental measure which excludes these charges allows management and investors to evaluate results “as-if” the acquired intangible assets had been developed internally rather than acquired and, therefore, provides a supplemental measure of performance in which our acquired intellectual property is treated in a comparable manner to our internally developed intellectual property. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Future acquisitions may result in the amortization of additional intangible assets.

Non-cash expenses.

We provide non-GAAP information relative to the following non-cash expenses: (i) stock-based compensation; and (ii) non-cash interest. These items are further discussed as follows:

(i)

Stock-based compensation. Because of varying valuation methodologies, subjective assumptions and the variety of award types, we exclude stock-based compensation from our operating results. We evaluate performance both with and without these measures because compensation expense related to stock-based compensation is typically non-cash and awards granted are influenced by the Company’s stock price and other factors such as volatility that are beyond our control. The expense related to stock-based awards is generally not controllable in the short-term and can vary significantly based on the timing, size and nature of awards granted. As such, we do not include such charges in operating plans. Stock-based compensation will continue in future periods.

(ii)

Non-cash interest. We exclude non-cash interest because we believe that excluding this expense provides management, as well as other users of the financial statements, with a valuable perspective on the cash-based performance and health of the business, including the current near-term projected liquidity. Non-cash interest expense will continue in future periods.

 

 

Other expenses.

We exclude certain other expenses that result from unplanned events outside the ordinary course of continuing operations, in order to measure operating performance and current and future liquidity both with and without these expenses. By providing this information, we believe management and the users of the financial statements are better able to understand the financial results of what we consider to be our organic, continuing operations. Included in these expenses are items such as other charges (credits), net, losses from extinguishment of debt, and changes in indemnification assets corresponding with the release of pre-spin liabilities for uncertain tax positions.

Adjustments to income tax provision.

Adjustments to our GAAP income tax provision to arrive at non-GAAP net income is determined based on our non-GAAP pre-tax income. Additionally, as our non-GAAP profitability is higher based on the non-GAAP adjustments, we adjust the GAAP tax provision to remove valuation allowances and related effects based on the higher level of reported non-GAAP profitability. We also exclude from our non-GAAP tax provision certain discrete tax items as they occur.

Bookings.

Bookings is defined as the amount of revenue we expect to earn from an agreement with our customers for products and services. To count as a booking, we expect there to be persuasive evidence of an arrangement, which may be evidenced by a legally binding document or documents, and that the collectability of the amounts payable under the arrangement are reasonably assured. The revenue we may actually recognize from our estimated bookings is subject to multiple factors, including but not limited to the timing of satisfying performance obligations, potential terminations, or changes in the scope of programs utilizing our technology and currency fluctuations. There is no comparable GAAP financial measure.

Key Performance Indicators

We believe that providing key performance indicators (“KPIs”) allows investors to gain insight into the way management views the performance of the business. We further believe that providing KPIs allows investors to better understand information used by management to evaluate and measure such performance. KPIs should not be considered superior to, or a substitute for, operating results prepared in accordance with GAAP. In assessing the performance of the business during the three months ended June 30, 2023, our management has reviewed the following KPIs, each of which is described below:

  • Percent of worldwide auto production with Cerence Technology: The number of Cerence enabled cars shipped as compared to IHS Markit car production data.

  • Average contract duration: The weighted average annual period over which we expect to recognize the estimated revenues from new license and connected contracts signed during the quarter, calculated on a trailing twelve months (“TTM”) basis and presented in years.

  • Repeatable software contribution: The percentage of repeatable revenues as compared to total GAAP revenue in the quarter on a TTM basis. Repeatable revenues are defined as the sum of License and Connected Services revenues.

  • Change in number of Cerence connected cars shipped: The year over year change in the number of cars shipped with Cerence connected solutions. Amounts calculated on a TTM basis.

  • Change in billings per car: The rate of growth calculated from the average billings per car based on a TTM basis, excluding professional services, legacy contract and adjusted for prepay usage.

See the tables at the end of this press release for non-GAAP reconciliations to the most directly comparable GAAP measures.

To learn more about Cerence, visit www.cerence.com, and follow the company on LinkedIn and Twitter.

About Cerence Inc.
Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the world’s leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, AI-powered interaction between humans and their vehicles, connecting consumers’ digital lives to their daily journeys no matter where they are. Cerence’s track record is built on more than 20 years of knowledge and 475 million cars shipped with Cerence technology. Whether it’s connected cars, autonomous driving, e-vehicles, or two-wheelers, Cerence is mapping the road ahead. For more information, visit www.cerence.com.

Contact Information

Rich Yerganian
Senior Vice President of Investor Relations
Cerence Inc.
Tel: 617-987-4799
Email: richard.yerganian@cerence.com


CERENCE INC.
Condensed Consolidated Statements of Operations
(in thousands, except per share data)

 

Three Months Ended

 

 

Nine Months Ended

 

 

June 30,

 

 

June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

License

$

25,837

 

 

$

46,452

 

 

$

102,054

 

 

$

139,610

 

Connected services

 

18,583

 

 

 

19,990

 

 

 

55,903

 

 

 

67,475

 

Professional services

 

17,240

 

 

 

22,599

 

 

 

55,754

 

 

 

62,662

 

Total revenues

 

61,660

 

 

 

89,041

 

 

 

213,711

 

 

 

269,747

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

License

 

2,343

 

 

 

585

 

 

 

6,166

 

 

 

1,692

 

Connected services

 

5,562

 

 

 

5,391

 

 

 

18,218

 

 

 

16,766

 

Professional services

 

12,930

 

 

 

18,173

 

 

 

47,441

 

 

 

51,448

 

Amortization of intangible assets

 

103

 

 

 

103

 

 

 

310

 

 

 

2,879

 

Total cost of revenues

 

20,938

 

 

 

24,252

 

 

 

72,135

 

 

 

72,785

 

Gross profit

 

40,722

 

 

 

64,789

 

 

 

141,576

 

 

 

196,962

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

30,202

 

 

 

26,040

 

 

 

88,190

 

 

 

81,808

 

Sales and marketing

 

4,277

 

 

 

8,299

 

 

 

21,656

 

 

 

22,487

 

General and administrative

 

13,019

 

 

 

10,614

 

 

 

46,453

 

 

 

31,941

 

Amortization of intangible assets

 

553

 

 

 

2,862

 

 

 

5,297

 

 

 

9,151

 

Restructuring and other costs, net

 

1,172

 

 

 

1,197

 

 

 

11,075

 

 

 

6,586

 

Total operating expenses

 

49,223

 

 

 

49,012

 

 

 

172,671

 

 

 

151,973

 

(Loss) income from operations

 

(8,501

)

 

 

15,777

 

 

 

(31,095

)

 

 

44,989

 

Interest income

 

1,207

 

 

 

243

 

 

 

3,240

 

 

 

416

 

Interest expense

 

(4,120

)

 

 

(3,815

)

 

 

(11,637

)

 

 

(10,602

)

Other income (expense), net

 

(2,030

)

 

 

(478

)

 

 

2,757

 

 

 

(764

)

(Loss) income before income taxes

 

(13,444

)

 

 

11,727

 

 

 

(36,735

)

 

 

34,039

 

Provision for income taxes

 

3,011

 

 

 

110,994

 

 

 

7,967

 

 

 

114,738

 

Net loss

$

(16,455

)

 

$

(99,267

)

 

$

(44,702

)

 

$

(80,699

)

Net loss per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.41

)

 

$

(2.53

)

 

$

(1.11

)

 

$

(2.06

)

Diluted

$

(0.41

)

 

$

(2.53

)

 

$

(1.11

)

 

$

(2.06

)

Weighted-average common share outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

40,324

 

 

 

39,313

 

 

 

40,167

 

 

 

39,113

 

Diluted

 

40,324

 

 

 

39,313

 

 

 

40,167

 

 

 

39,113

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CERENCE INC.
Condensed Consolidated Balance Sheets
(in thousands, except per share amounts)

 

June 30,

 

 

September 30,

 

 

2023

 

 

2022

 

 

(Unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

86,100

 

 

 

94,847

 

Marketable securities

 

16,717

 

 

 

20,317

 

Accounts receivable, net of allowances of $4,048 and $157

 

56,984

 

 

 

45,073

 

Deferred costs

 

7,585

 

 

 

7,098

 

Prepaid expenses and other current assets

 

51,748

 

 

 

60,184

 

Total current assets

 

219,134

 

 

 

227,519

 

Long-term marketable securities

 

13,194

 

 

 

11,584

 

Property and equipment, net

 

34,924

 

 

 

37,707

 

Deferred costs

 

20,875

 

 

 

22,451

 

Operating lease right of use assets

 

13,445

 

 

 

14,702

 

Goodwill

 

904,910

 

 

 

890,802

 

Intangible assets, net

 

4,644

 

 

 

9,700

 

Deferred tax assets

 

52,198

 

 

 

51,989

 

Other assets

 

48,854

 

 

 

52,039

 

Total assets

$

1,312,178

 

 

$

1,318,493

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

16,118

 

 

$

10,372

 

Deferred revenue

 

75,296

 

 

 

72,662

 

Short-term operating lease liabilities

 

5,505

 

 

 

5,071

 

Short-term debt

 

24,700

 

 

 

10,938

 

Accrued expenses and other current liabilities

 

46,802

 

 

 

47,990

 

Total current liabilities

 

168,421

 

 

 

147,033

 

Long-term debt

 

254,702

 

 

 

259,436

 

Deferred revenue, net of current portion

 

153,002

 

 

 

165,972

 

Long-term operating lease liabilities

 

9,330

 

 

 

11,375

 

Other liabilities

 

23,909

 

 

 

21,727

 

Total liabilities

 

609,364

 

 

 

605,543

 

Stockholders' Equity:

 

 

 

 

 

Common stock, $0.01 par value, 560,000 shares authorized; 40,333 and 39,430 shares issued and outstanding, respectively

 

403

 

 

 

394

 

Accumulated other comprehensive loss

 

(24,652

)

 

 

(33,737

)

Additional paid-in capital

 

1,049,173

 

 

 

1,029,542

 

Accumulated deficit

 

(322,110

)

 

 

(283,249

)

Total stockholders' equity

 

702,814

 

 

 

712,950

 

Total liabilities and stockholders' equity

$

1,312,178

 

 

$

1,318,493

 

 

 

 

 

 

 

 

 

CERENCE INC.
Condensed Consolidated Statements of Cash Flows
(in thousands)

 

Nine Months Ended

 

 

June 30,

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

$

(44,702

)

 

$

(80,699

)

Adjustments to reconcile net loss to net cash (used in) provided by operations:

 

 

 

 

 

Depreciation and amortization

 

13,151

 

 

 

18,853

 

Provision for (benefit from) credit loss reserve

 

3,626

 

 

 

(414

)

Stock-based compensation

 

31,801

 

 

 

23,020

 

Non-cash interest expense

 

1,450

 

 

 

3,922

 

Loss on debt extinguishment

 

1,333

 

 

 

-

 

Deferred tax benefit

 

1,536

 

 

 

103,394

 

Unrealized foreign currency transaction (gain) losses

 

(5,441

)

 

 

4,854

 

Other

 

(4,004

)

 

 

283

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(10,951

)

 

 

(21,626

)

Prepaid expenses and other assets

 

19,902

 

 

 

(34,621

)

Deferred costs

 

2,511

 

 

 

3,753

 

Accounts payable

 

4,799

 

 

 

4,638

 

Accrued expenses and other liabilities

 

(334

)

 

 

(2,698

)

Deferred revenue

 

(18,437

)

 

 

(19,844

)

Net cash (used in) provided by operating activities

 

(3,760

)

 

 

2,815

 

Cash flows from investing activities:

 

 

 

 

 

Capital expenditures

 

(3,597

)

 

 

(14,418

)

Purchases of marketable securities

 

(18,025

)

 

 

(21,153

)

Sale and maturities of marketable securities

 

20,200

 

 

 

31,003

 

Payments for equity investments

 

-

 

 

 

(584

)

Other investing activities

 

(1,024

)

 

 

1,735

 

Net cash used in investing activities

 

(2,446

)

 

 

(3,417

)

Cash flows from financing activities:

 

 

 

 

 

Proceeds from revolving credit facility

 

24,700

 

 

 

-

 

Proceeds from long-term debt, net of discount

 

190,000

 

 

 

-

 

Payments for long-term debt issuance costs

 

(16,786

)

 

 

-

 

Principal payments of long-term debt

 

(198,438

)

 

 

(4,689

)

Common stock repurchases for tax withholdings for net settlement of equity awards

 

(4,834

)

 

 

(47,960

)

Principal payment of lease liabilities arising from a finance lease

 

(355

)

 

 

(289

)

Proceeds from the issuance of common stock

 

4,687

 

 

 

34,943

 

Net cash used in financing activities

 

(1,026

)

 

 

(17,995

)

Effects of exchange rate changes on cash and cash equivalents

 

(1,515

)

 

 

(1,377

)

Net change in cash and cash equivalents

 

(8,747

)

 

 

(19,974

)

Cash and cash equivalents at beginning of period

 

94,847

 

 

 

128,428

 

Cash and cash equivalents at end of period

$

86,100

 

 

$

108,454

 

 

 

 

 

 

 

 

 

CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures
(unaudited - in thousands)

 

Three Months Ended

 

 

Nine Months Ended

 

 

June 30,

 

 

June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

GAAP revenue

$

61,660

 

 

$

89,041

 

 

$

213,711

 

 

$

269,747

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

40,722

 

 

$

64,789

 

 

$

141,576

 

 

$

196,962

 

Stock-based compensation

 

163

 

 

 

722

 

 

 

2,699

 

 

 

3,384

 

Amortization of intangible assets

 

103

 

 

 

103

 

 

 

310

 

 

 

2,879

 

Non-GAAP gross profit

$

40,988

 

 

$

65,614

 

 

$

144,585

 

 

$

203,225

 

GAAP gross margin

 

66.0

%

 

 

72.8

%

 

 

66.2

%

 

 

73.0

%

Non-GAAP gross margin

 

66.5

%

 

 

73.7

%

 

 

67.7

%

 

 

75.3

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating (loss) income

$

(8,501

)

 

$

15,777

 

 

$

(31,095

)

 

$

44,989

 

Stock-based compensation*

 

6,974

 

 

 

6,253

 

 

 

31,801

 

 

 

19,020

 

Amortization of intangible assets

 

656

 

 

 

2,965

 

 

 

5,607

 

 

 

12,030

 

Restructuring and other costs, net*

 

1,172

 

 

 

1,197

 

 

 

11,075

 

 

 

6,586

 

Non-GAAP operating income

$

301

 

 

$

26,192

 

 

$

17,388

 

 

$

82,625

 

GAAP operating margin

 

-13.8

%

 

 

17.7

%

 

 

-14.6

%

 

 

16.7

%

Non-GAAP operating margin

 

0.5

%

 

 

29.4

%

 

 

8.1

%

 

 

30.6

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss

$

(16,455

)

 

$

(99,267

)

 

$

(44,702

)

 

$

(80,699

)

Stock-based compensation*

 

6,974

 

 

 

6,253

 

 

 

31,801

 

 

 

19,020

 

Amortization of intangible assets

 

656

 

 

 

2,965

 

 

 

5,607

 

 

 

12,030

 

Restructuring and other costs, net*

 

1,172

 

 

 

1,197

 

 

 

11,075

 

 

 

6,586

 

Depreciation

 

2,462

 

 

 

2,314

 

 

 

7,544

 

 

 

6,823

 

Total other expense, net

 

(4,943

)

 

 

(4,050

)

 

 

(5,640

)

 

 

(10,950

)

Provision for income taxes

 

3,011

 

 

 

110,994

 

 

 

7,967

 

 

 

114,738

 

Adjusted EBITDA

$

2,763

 

 

$

28,506

 

 

$

24,932

 

 

$

89,448

 

GAAP net loss margin

 

-26.7

%

 

 

-111.5

%

 

 

-20.9

%

 

 

-29.9

%

Adjusted EBITDA margin

 

4.5

%

 

 

32.0

%

 

 

11.7

%

 

 

33.2

%

* - $4.0 million in stock-based compensation is included in Restructuring and other costs, net during Q1'22.

 

 

 

CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)
(unaudited - in thousands, except per share data)

 

Three Months Ended

 

 

Nine Months Ended

 

 

June 30,

 

 

June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

GAAP net loss

$

(16,455

)

 

$

(99,267

)

 

$

(44,702

)

 

$

(80,699

)

Stock-based compensation*

 

6,974

 

 

 

6,253

 

 

 

31,801

 

 

 

19,020

 

Amortization of intangible assets

 

656

 

 

 

2,965

 

 

 

5,607

 

 

 

12,030

 

Restructuring and other costs, net*

 

1,172

 

 

 

1,197

 

 

 

11,075

 

 

 

6,586

 

Loss on debt extinguishment

 

1,333

 

 

 

-

 

 

 

1,333

 

 

 

-

 

Non-cash interest expense

 

540

 

 

 

1,327

 

 

 

1,450

 

 

 

3,922

 

Indemnification asset release

 

-

 

 

 

-

 

 

 

-

 

 

 

1,302

 

Other

 

(25

)

 

 

-

 

 

 

(844

)

 

 

-

 

Adjustments to income tax expense

 

4,144

 

 

 

104,487

 

 

 

5,107

 

 

 

93,768

 

Non-GAAP net (loss) income

$

(1,661

)

 

$

16,962

 

 

$

10,827

 

 

$

55,929

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EPS:

 

 

 

 

 

 

 

 

 

 

 

GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net loss attributed to common shareholders - basic and diluted

$

(16,455

)

 

$

(99,267

)

 

$

(44,702

)

 

$

(80,699

)

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributed to common shareholders - basic

$

(1,661

)

 

$

16,962

 

 

$

10,827

 

 

$

55,929

 

Interest on the Notes, net of tax

 

-

 

 

 

-

 

 

 

 

 

 

3,024

 

Net (loss) income attributed to common shareholders - diluted

$

(1,661

)

 

$

16,962

 

 

$

10,827

 

 

$

58,953

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic and diluted

 

40,324

 

 

 

39,313

 

 

 

40,167

 

 

 

39,113

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding- basic

 

40,324

 

 

 

39,313

 

 

 

40,167

 

 

 

39,113

 

Adjustment for diluted shares

 

-

 

 

 

-

 

 

 

197

 

 

 

5,046

 

Weighted-average common shares outstanding - diluted

 

40,324

 

 

 

39,313

 

 

 

40,364

 

 

 

44,159

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss per share - diluted

$

(0.41

)

 

$

(2.53

)

 

$

(1.11

)

 

$

(2.06

)

Non-GAAP net (loss) income per share - diluted

$

(0.04

)

 

$

0.43

 

 

$

0.27

 

 

$

1.34

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net cash (used in) provided by operating activities

$

(8,197

)

 

$

(3,928

)

 

$

(3,760

)

 

$

2,815

 

Capital expenditures

 

(1,520

)

 

 

(4,433

)

 

 

(3,597

)

 

 

(14,418

)

Free Cash Flow

$

(9,717

)

 

$

(8,361

)

 

$

(7,357

)

 

$

(11,603

)

* - $4.0 million in stock-based compensation is included in Restructuring and other costs, net during Q1'22.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)
(unaudited - in thousands)

 

Q3FY23

 

 

Q2FY23

 

 

Q1FY23

 

 

Q4FY22

 

GAAP revenues

$

61,660

 

 

$

68,393

 

 

$

83,658

 

 

$

58,144

 

Less: Professional services revenue

 

17,240

 

 

 

18,667

 

 

 

19,847

 

 

 

21,048

 

Non-GAAP Repeatable revenues

$

44,420

 

 

$

49,726

 

 

$

63,811

 

 

$

37,096

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP revenues TTM

$

271,855

 

 

 

 

 

 

 

 

 

 

Less: Professional services revenue TTM

 

76,802

 

 

 

 

 

 

 

 

 

 

Non-GAAP Repeatable revenues TTM

$

195,053

 

 

 

 

 

 

 

 

 

 

Repeatable software contribution

 

72

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)
(unaudited - in thousands)

 

Q4 2023

 

 

FY2023

 

 

Low

 

 

High

 

 

Low

 

 

High

 

GAAP revenue

$

72,000

 

 

$

76,000

 

 

$

285,700

 

 

$

289,700

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

50,500

 

 

$

54,500

 

 

$

192,100

 

 

$

196,100

 

Stock-based compensation

 

1,000

 

 

 

1,000

 

 

 

3,700

 

 

 

3,700

 

Amortization of intangible assets

 

100

 

 

 

100

 

 

 

400

 

 

 

400

 

Non-GAAP gross profit

$

51,600

 

 

$

55,600

 

 

$

196,200

 

 

$

200,200

 

GAAP gross margin

 

70

%

 

 

72

%

 

 

67

%

 

 

68

%

Non-GAAP gross margin

 

72

%

 

 

73

%

 

 

69

%

 

 

69

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating loss

$

(5,800

)

 

$

(1,800

)

 

$

(37,000

)

 

$

(33,000

)

Stock-based compensation

 

11,800

 

 

 

11,800

 

 

 

43,600

 

 

 

43,600

 

Amortization of intangible assets

 

600

 

 

 

600

 

 

 

6,200

 

 

 

6,200

 

Restructuring and other costs, net

 

800

 

 

 

800

 

 

 

11,900

 

 

 

11,900

 

Non-GAAP operating income

$

7,400

 

 

$

11,400

 

 

$

24,700

 

 

$

28,700

 

GAAP operating margin

 

-8

%

 

 

-2

%

 

 

-13

%

 

 

-11

%

Non-GAAP operating margin

 

10

%

 

 

15

%

 

 

9

%

 

 

10

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss

$

(12,700

)

 

$

(8,700

)

 

$

(57,500

)

 

$

(53,500

)

Stock-based compensation

 

11,800

 

 

 

11,800

 

 

 

43,600

 

 

 

43,600

 

Amortization of intangible assets

 

600

 

 

 

600

 

 

 

6,200

 

 

 

6,200

 

Restructuring and other costs, net

 

800

 

 

 

800

 

 

 

11,900

 

 

 

11,900

 

Depreciation

 

2,100

 

 

 

2,100

 

 

 

9,700

 

 

 

9,700

 

Total other income (expense), net

 

(1,900

)

 

 

(1,900

)

 

 

(7,500

)

 

 

(7,500

)

Provision for income taxes

 

5,000

 

 

 

5,000

 

 

 

13,000

 

 

 

13,000

 

Adjusted EBITDA

$

9,500

 

 

$

13,500

 

 

$

34,400

 

 

$

38,400

 

GAAP net loss margin

 

-18

%

 

 

-11

%

 

 

-20

%

 

 

-18

%

Adjusted EBITDA margin

 

13

%

 

 

18

%

 

 

12

%

 

 

13

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)
(unaudited - in thousands, except per share data)

 

Q4 2023

 

 

FY2023

 

 

Low

 

 

High

 

 

Low

 

 

High

 

GAAP net loss

$

(12,700

)

 

$

(8,700

)

 

$

(57,500

)

 

$

(53,500

)

Stock-based compensation

 

11,800

 

 

 

11,800

 

 

 

43,600

 

 

 

43,600

 

Amortization of intangibles

 

600

 

 

 

600

 

 

 

6,200

 

 

 

6,200

 

Restructuring and other costs, net

 

800

 

 

 

800

 

 

 

11,900

 

 

 

11,900

 

Loss on debt extinguishment

 

-

 

 

 

-

 

 

 

1,300

 

 

 

1,300

 

Non-cash interest expense

 

1,400

 

 

 

1,400

 

 

 

2,900

 

 

 

2,900

 

Other

 

-

 

 

 

-

 

 

 

(900

)

 

 

(900

)

Adjustments to income tax expense

 

1,400

 

 

 

1,400

 

 

 

6,600

 

 

 

6,600

 

Non-GAAP net income

$

3,300

 

 

$

7,300

 

 

$

14,100

 

 

$

18,100

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EPS:

 

 

 

 

 

 

 

 

 

 

 

GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net loss attributed to common shareholders - basic and diluted

$

(12,700

)

 

$

(8,700

)

 

$

(57,500

)

 

$

(53,500

)

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income attributed to common shareholders - basic and diluted

$

3,300

 

 

$

7,300

 

 

$

14,100

 

 

$

18,100

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic and diluted

 

40,400

 

 

 

40,400

 

 

 

40,200

 

 

 

40,200

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding- basic

 

40,400

 

 

 

40,400

 

 

 

40,200

 

 

 

40,200

 

Adjustment for diluted shares

 

1,200

 

 

 

1,200

 

 

 

400

 

 

 

400

 

Weighted-average common shares outstanding - diluted

 

41,600

 

 

 

41,600

 

 

 

40,600

 

 

 

40,600

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss per share - diluted

$

(0.31

)

 

$

(0.22

)

 

$

(1.43

)

 

$

(1.33

)

Non-GAAP net income per share - diluted

$

0.08

 

 

$

0.18

 

 

$

0.35

 

 

$

0.45

 


Advertisement